001     278371
005     20240229155031.0
024 7 _ |a 10.1186/s13058-023-01691-8
|2 doi
024 7 _ |a pmid:37559094
|2 pmid
024 7 _ |a 1465-5411
|2 ISSN
024 7 _ |a 1465-542X
|2 ISSN
024 7 _ |a altmetric:152753744
|2 altmetric
037 _ _ |a DKFZ-2023-01621
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Middha, Pooja
|0 P:(DE-He78)ab36c38b48e62919a71022ba71822570
|b 0
|e First author
245 _ _ |a A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry.
260 _ _ |a London
|c 2023
|b BioMed Central
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1691673968_941
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:C020#LA:C020#
520 _ _ |a Genome-wide studies of gene-environment interactions (G×E) may identify variants associated with disease risk in conjunction with lifestyle/environmental exposures. We conducted a genome-wide G×E analysis of ~ 7.6 million common variants and seven lifestyle/environmental risk factors for breast cancer risk overall and for estrogen receptor positive (ER +) breast cancer.Analyses were conducted using 72,285 breast cancer cases and 80,354 controls of European ancestry from the Breast Cancer Association Consortium. Gene-environment interactions were evaluated using standard unconditional logistic regression models and likelihood ratio tests for breast cancer risk overall and for ER + breast cancer. Bayesian False Discovery Probability was employed to assess the noteworthiness of each SNP-risk factor pairs.Assuming a 1 × 10-5 prior probability of a true association for each SNP-risk factor pairs and a Bayesian False Discovery Probability < 15%, we identified two independent SNP-risk factor pairs: rs80018847(9p13)-LINGO2 and adult height in association with overall breast cancer risk (ORint = 0.94, 95% CI 0.92-0.96), and rs4770552(13q12)-SPATA13 and age at menarche for ER + breast cancer risk (ORint = 0.91, 95% CI 0.88-0.94).Overall, the contribution of G×E interactions to the heritability of breast cancer is very small. At the population level, multiplicative G×E interactions do not make an important contribution to risk prediction in breast cancer.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Breast cancer
|2 Other
650 _ 7 |a European ancestry
|2 Other
650 _ 7 |a Gene-environment interactions
|2 Other
650 _ 7 |a Genetic epidemiology
|2 Other
700 1 _ |a Wang, Xiaoliang
|b 1
700 1 _ |a Behrens, Sabine
|0 P:(DE-He78)6b04712f3afe72044d496a25505cb1ea
|b 2
|u dkfz
700 1 _ |a Bolla, Manjeet K
|b 3
700 1 _ |a Wang, Qin
|b 4
700 1 _ |a Dennis, Joe
|b 5
700 1 _ |a Michailidou, Kyriaki
|b 6
700 1 _ |a Ahearn, Thomas U
|b 7
700 1 _ |a Andrulis, Irene L
|b 8
700 1 _ |a Anton-Culver, Hoda
|b 9
700 1 _ |a Arndt, Volker
|0 P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0
|b 10
|u dkfz
700 1 _ |a Aronson, Kristan J
|b 11
700 1 _ |a Auer, Paul L
|b 12
700 1 _ |a Augustinsson, Annelie
|b 13
700 1 _ |a Baert, Thaïs
|b 14
700 1 _ |a Freeman, Laura E Beane
|b 15
700 1 _ |a Becher, Heiko
|b 16
700 1 _ |a Beckmann, Matthias W
|b 17
700 1 _ |a Benitez, Javier
|b 18
700 1 _ |a Bojesen, Stig E
|b 19
700 1 _ |a Brauch, Hiltrud
|b 20
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 21
|u dkfz
700 1 _ |a Brooks-Wilson, Angela
|b 22
700 1 _ |a Campa, Daniele
|0 P:(DE-HGF)0
|b 23
700 1 _ |a Canzian, Federico
|0 P:(DE-He78)5323704270b6393dcea70186ffd86bca
|b 24
|u dkfz
700 1 _ |a Carracedo, Angel
|b 25
700 1 _ |a Castelao, Jose E
|b 26
700 1 _ |a Chanock, Stephen J
|b 27
700 1 _ |a Chenevix-Trench, Georgia
|b 28
700 1 _ |a Consortium, CTS
|b 29
|e Collaboration Author
700 1 _ |a Cordina-Duverger, Emilie
|b 30
700 1 _ |a Couch, Fergus J
|b 31
700 1 _ |a Cox, Angela
|b 32
700 1 _ |a Cross, Simon S
|b 33
700 1 _ |a Czene, Kamila
|b 34
700 1 _ |a Dossus, Laure
|b 35
700 1 _ |a Dugué, Pierre-Antoine
|b 36
700 1 _ |a Eliassen, A Heather
|b 37
700 1 _ |a Eriksson, Mikael
|b 38
700 1 _ |a Evans, D Gareth
|b 39
700 1 _ |a Fasching, Peter A
|b 40
700 1 _ |a Figueroa, Jonine D
|b 41
700 1 _ |a Fletcher, Olivia
|b 42
700 1 _ |a Flyger, Henrik
|b 43
700 1 _ |a Gabrielson, Marike
|b 44
700 1 _ |a Gago-Dominguez, Manuela
|b 45
700 1 _ |a Giles, Graham G
|b 46
700 1 _ |a González-Neira, Anna
|b 47
700 1 _ |a Grassmann, Felix
|b 48
700 1 _ |a Grundy, Anne
|b 49
700 1 _ |a Guénel, Pascal
|b 50
700 1 _ |a Haiman, Christopher A
|b 51
700 1 _ |a Håkansson, Niclas
|b 52
700 1 _ |a Hall, Per
|b 53
700 1 _ |a Hamann, Ute
|0 P:(DE-He78)537e07b3e57b16c7b214fc2242e4326b
|b 54
|u dkfz
700 1 _ |a Hankinson, Susan E
|b 55
700 1 _ |a Harkness, Elaine F
|b 56
700 1 _ |a Holleczek, Bernd
|b 57
700 1 _ |a Hoppe, Reiner
|b 58
700 1 _ |a Hopper, John L
|b 59
700 1 _ |a Houlston, Richard S
|b 60
700 1 _ |a Howell, Anthony
|b 61
700 1 _ |a Hunter, David J
|b 62
700 1 _ |a Ingvar, Christian
|b 63
700 1 _ |a Investigators, ABCTB
|b 64
|e Collaboration Author
700 1 _ |a Investigators, kConFab
|b 65
|e Collaboration Author
700 1 _ |a Isaksson, Karolin
|b 66
700 1 _ |a Jernström, Helena
|b 67
700 1 _ |a John, Esther M
|b 68
700 1 _ |a Jones, Michael E
|b 69
700 1 _ |a Kaaks, Rudolf
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 70
|u dkfz
700 1 _ |a Keeman, Renske
|b 71
700 1 _ |a Kitahara, Cari M
|b 72
700 1 _ |a Ko, Yon-Dschun
|b 73
700 1 _ |a Koutros, Stella
|b 74
700 1 _ |a Kurian, Allison W
|b 75
700 1 _ |a Lacey, James V
|b 76
700 1 _ |a Lambrechts, Diether
|b 77
700 1 _ |a Larson, Nicole L
|b 78
700 1 _ |a Larsson, Susanna
|b 79
700 1 _ |a Le Marchand, Loic
|b 80
700 1 _ |a Lejbkowicz, Flavio
|b 81
700 1 _ |a Li, Shuai
|b 82
700 1 _ |a Linet, Martha
|b 83
700 1 _ |a Lissowska, Jolanta
|b 84
700 1 _ |a Martinez, Maria Elena
|b 85
700 1 _ |a Maurer, Tabea
|b 86
700 1 _ |a Mulligan, Anna Marie
|b 87
700 1 _ |a Mulot, Claire
|b 88
700 1 _ |a Murphy, Rachel A
|b 89
700 1 _ |a Newman, William G
|b 90
700 1 _ |a Nielsen, Sune F
|b 91
700 1 _ |a Nordestgaard, Børge G
|b 92
700 1 _ |a Norman, Aaron
|b 93
700 1 _ |a O'Brien, Katie M
|b 94
700 1 _ |a Olson, Janet E
|b 95
700 1 _ |a Patel, Alpa V
|b 96
700 1 _ |a Prentice, Ross
|b 97
700 1 _ |a Rees-Punia, Erika
|b 98
700 1 _ |a Rennert, Gad
|b 99
700 1 _ |a Rhenius, Valerie
|b 100
700 1 _ |a Ruddy, Kathryn J
|b 101
700 1 _ |a Sandler, Dale P
|b 102
700 1 _ |a Scott, Christopher G
|b 103
700 1 _ |a Shah, Mitul
|b 104
700 1 _ |a Shu, Xiao-Ou
|b 105
700 1 _ |a Smeets, Ann
|b 106
700 1 _ |a Southey, Melissa C
|b 107
700 1 _ |a Stone, Jennifer
|b 108
700 1 _ |a Tamimi, Rulla M
|b 109
700 1 _ |a Taylor, Jack A
|b 110
700 1 _ |a Teras, Lauren R
|b 111
700 1 _ |a Tomczyk, Katarzyna
|b 112
700 1 _ |a Troester, Melissa A
|b 113
700 1 _ |a Truong, Thérèse
|b 114
700 1 _ |a Vachon, Celine M
|b 115
700 1 _ |a Wang, Sophia S
|b 116
700 1 _ |a Weinberg, Clarice R
|b 117
700 1 _ |a Wildiers, Hans
|b 118
700 1 _ |a Willett, Walter
|b 119
700 1 _ |a Winham, Stacey J
|b 120
700 1 _ |a Wolk, Alicja
|b 121
700 1 _ |a Yang, Xiaohong R
|b 122
700 1 _ |a Zamora, M Pilar
|b 123
700 1 _ |a Zheng, Wei
|b 124
700 1 _ |a Ziogas, Argyrios
|b 125
700 1 _ |a Dunning, Alison M
|b 126
700 1 _ |a Pharoah, Paul D P
|b 127
700 1 _ |a García-Closas, Montserrat
|b 128
700 1 _ |a Schmidt, Marjanka K
|b 129
700 1 _ |a Kraft, Peter
|b 130
700 1 _ |a Milne, Roger L
|b 131
700 1 _ |a Lindström, Sara
|b 132
700 1 _ |a Easton, Douglas F
|b 133
700 1 _ |a Chang-Claude, Jenny
|0 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
|b 134
|e Last author
|u dkfz
773 _ _ |a 10.1186/s13058-023-01691-8
|g Vol. 25, no. 1, p. 93
|0 PERI:(DE-600)2041618-0
|n 1
|p 93
|t Breast cancer research
|v 25
|y 2023
|x 1465-5411
909 C O |o oai:inrepo02.dkfz.de:278371
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)ab36c38b48e62919a71022ba71822570
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)6b04712f3afe72044d496a25505cb1ea
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 21
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 23
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 24
|6 P:(DE-He78)5323704270b6393dcea70186ffd86bca
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 54
|6 P:(DE-He78)537e07b3e57b16c7b214fc2242e4326b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 70
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 134
|6 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2023
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-03-30
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2023-03-30
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2023-03-30
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BREAST CANCER RES : 2022
|d 2023-08-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-08-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-05-02T09:05:15Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-05-02T09:05:15Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2023-05-02T09:05:15Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-08-26
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b BREAST CANCER RES : 2022
|d 2023-08-26
920 2 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 1
920 1 _ |0 I:(DE-He78)C120-20160331
|k C120
|l Präventive Onkologie
|x 2
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 3
920 1 _ |0 I:(DE-He78)C055-20160331
|k C055
|l C055 Genomische Epidemiologie
|x 4
920 1 _ |0 I:(DE-He78)B072-20160331
|k B072
|l Molekulargenetik des Mammakarzinoms
|x 5
920 0 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)C120-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a I:(DE-He78)C055-20160331
980 _ _ |a I:(DE-He78)B072-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21